Impact of device implantation depth on blood flow dynamics after left atrial appendage closure
BACKGROUND: Device-related thrombus (DRT) remains a concern after left atrial appendage closure (LAAC), particularly when the device is deeply implanted. However, the mechanistic links between implantation depth, flow dynamics, and DRT risk are not well understood. AIMS: We therefore aimed to evaluate the impact of LAAC device implantation depth on local flow characteristics and its association with DRT using patient-specific computational fluid dynamics (CFD). METHODS: The study included 285 patients undergoing LAAC with either Amplatzer Amulet or WATCHMAN devices at 10 centres. Patient-specific CFD simulations were performed using postprocedural computed tomography and echocardiography-derived boundary conditions to assess blood flow dynamics. The primary endpoint was the comparison of CFD-derived flow indices - device surface velocity index (DSVI), endothelial cell activation potential (ECAP), and the presence of eddies/stagnated flow - between proximal and distal device implantation groups. Secondary analyses explored the relationship between these flow features and DRT. RESULTS: Proximal implants (57.2%) showed more favourable flow patterns: higher DSVI (0.11 m/s vs 0.09 m/s; p=0.002), lower ECAP (0.75 vs 0.90; p=0.003), and fewer recirculating zones (40.5% vs 74.6%; p<0.001). DRT incidence increased with greater implantation depth, paralleled by worsening flow indices. A composite CFD-based DRT risk score, incorporating ECAP, implantation depth, and flow complexity, demonstrated good discrimination (area under the receiver operating characteristic curve [AUC] 0.81), outperforming anatomical depth alone (AUC 0.71). CONCLUSIONS: Deeper LAAC device implantation is associated with adverse flow profiles and a higher risk of DRT. CFD-based flow characterisation may enhance risk stratification beyond anatomical criteria alone. Further studies incorporating clinical variables are warranted to validate these methods.
Authors
- Jérôme Horvilleur (ORCID: https://orcid.org/0009-0000-6102-4709)
- Kasper Korsholm (ORCID: https://orcid.org/0000-0003-4724-0880)
- Adel Aminian (ORCID: https://orcid.org/0000-0002-4667-9181)
- Laura Sanchís (ORCID: https://orcid.org/0000-0003-2516-8953)
- Nina Leduc
- Carlos Albors (ORCID: https://orcid.org/0000-0002-9229-9518)
- Marisa Avvedimento (ORCID: https://orcid.org/0000-0002-8443-7888)
- Jordi Mill (ORCID: https://orcid.org/0000-0003-0087-7489)
- Manuel Barreiro‐Pérez (ORCID: https://orcid.org/0000-0001-7489-2935)
- Ana Lafond
- Manal Barrouhou
- Oscar Camara
- Dabit Arzamendi
- Xavi Millán
- Klaus Fuglsang Kofoed
- Josep Rodés-Cabau
- Ole De Backer
- Pedro Cepas-Guillén
- Rodrigo Estevez-Loureiro
- Xavier Iriart
- Xavier Freixa
- Jens Erik Nielsen-Kudsk
- Eduardo Flores-Umanzor
- Hubert Cochet
- Luis Nombela-Franco
- Philippe Garot
- Ignacio Cruz-González
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Universitat Pompeu Fabra (ES)
- Hospital de Sant Pau (ES)
- Aarhus University Hospital (DK)
- University Hospital Complex Of Vigo (ES)
- Rigshospitalet (DK)
- Hospital Clínico San Carlos (ES)
- Electrophysiology and Heart Modeling Institute (FR)
- Galicia Sur Biomedical Foundation (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Hospital Clínic de Barcelona (ES)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Institut Cardiovasculaire Paris Sud (FR)
- Grand Charleroi Hospital (BE)
- Université Laval (CA)
Publication Details
- Journal
- EuroIntervention
- Published
- 2026-04-01
- DOI
- https://doi.org/10.4244/eij-d-25-01328
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00